Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study

  1. Sánchez, M.A.
  2. Marín, F.
  3. Masjuan, J.
  4. Cosín-Sales, J.
  5. Rodríguez, J.M.V.
  6. Barrios, V.
  7. Barón-Esquivias, G.
  8. Lekuona, I.
  9. Pérez-Cabeza, A.I.
  10. Freixa-Pamias, R.
  11. Jimenez, F.J.P.
  12. Khatib, M.M.K.
  13. Priu, C.R.
  14. Fernández, M.S.
Aldizkaria:
Cardiology Journal

ISSN: 1898-018X,  1897-5593

Argitalpen urtea: 2022

Alea: 29

Zenbakia: 6

Orrialdeak: 936-947

Mota: Artikulua

DOI: 10.5603/CJ.A2022.0091 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus